- Home
- APYX vs BYSI Comparison
APYX vs BYSI Comparison
Compare APYX & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APYX
- BYSI
- Stock Information
- Founded
- APYX 1982
- BYSI 2010
- Country
- APYX United States
- BYSI United States
- Employees
- APYX N/A
- BYSI N/A
- Industry
- APYX Medical/Dental Instruments
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- APYX Health Care
- BYSI Health Care
- Exchange
- APYX Nasdaq
- BYSI Nasdaq
- Market Cap
- APYX 66.5M
- BYSI 71.0M
- IPO Year
- APYX 1987
- BYSI 2017
- Fundamental
- Price
- APYX $2.25
- BYSI $2.39
- Analyst Decision
- APYX Hold
- BYSI
- Analyst Count
- APYX 2
- BYSI 0
- Target Price
- APYX N/A
- BYSI N/A
- AVG Volume (30 Days)
- APYX 72.0K
- BYSI 150.3K
- Earning Date
- APYX 08-07-2025
- BYSI 08-11-2025
- Dividend Yield
- APYX N/A
- BYSI N/A
- EPS Growth
- APYX N/A
- BYSI N/A
- EPS
- APYX N/A
- BYSI N/A
- Revenue
- APYX $47,288,000.00
- BYSI N/A
- Revenue This Year
- APYX $2.25
- BYSI N/A
- Revenue Next Year
- APYX $6.76
- BYSI N/A
- P/E Ratio
- APYX N/A
- BYSI N/A
- Revenue Growth
- APYX N/A
- BYSI N/A
- 52 Week Low
- APYX $0.76
- BYSI $0.98
- 52 Week High
- APYX $2.30
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- APYX 62.48
- BYSI 54.10
- Support Level
- APYX $1.84
- BYSI $2.31
- Resistance Level
- APYX $2.29
- BYSI $3.44
- Average True Range (ATR)
- APYX 0.21
- BYSI 0.43
- MACD
- APYX 0.02
- BYSI -0.03
- Stochastic Oscillator
- APYX 84.09
- BYSI 48.52
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.